Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
stimulates periosteal bone formation in monkeys
6(10):e25134
AA92593 was used at 10 µM final concentration in various in vitro assays
2016 May 6
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Delamanid (OPC-67683) - CAS# 681492-22-8 60233 stimulates periosteal bone formation inDelamanid (OPC 67683), CAS No. 681492 22 8, also known as OPC 67683, is a drug for the treatment of multi drug resistant tuberculosis. It works by blocking the synthesis of mycolic acids in Mycobacterium tuberculosis, the organism which causes tuberculosis, thus destabilising its cell wall. The drug is approved in the EU. Delamanid inhibits the synthesis of mycolic acids, crucial component of the cell wall of the Mycobacterium tuberculosis complex.